ABBV · 10-Q · 2026Q3 · Full report

Income Tax Rate Changes

AbbVie Inc. · 2026-11-03 · Importance 57 · Surprise 64 · In source text

AbbVie’s effective tax rate was 13% for the third quarter and 16% for the first nine months of 2026, compared with 74% and 39%, respectively, in 2025. The decreases primarily reflected a reduced impact from business-development activities and fair-value changes in contingent consideration. Lower tax rates on foreign operations also kept the effective rate below the 21% U.S. statutory rate, partly offset by fair-value and business-development impacts.

Key facts

• AbbVie’s effective tax rate was 13% for the three months and 16% for the nine months ended September 30, 2026, compared with 74% and 39%, respectively, in 2025; the U.S. statutory rate was 21%. source
• The effective tax rate decreased in the three and nine months ended September 30, 2026 versus the prior year, primarily because business-development activities and contingent-consideration fair-value changes had a reduced impact, partly offset by changes in the impact of foreign operations. source

Impact estimates